Cancer therapy has advanced with molecularly targeted approaches and immunotherapy, yet chemotherapy remains essential for ...

Life science firm Nuvation Bio raised $250 million to bring its novel lung cancer therapy to market and help it reach ...

Immune checkpoint inhibitors (ICPis) have revolutionized the therapeutic landscape of lung cancer with unprecedented survival results in most of the ...

Gunnar Boysen, an associate professor of environmental and occupational health at UAMS, will discuss his work studying tumor metabolism and using advanced therapy approaches this Wednesday.

BERLIN, Feb. 6, 2025 /PRNewswire/ -- Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical ... of patients with Small Cell Lung Cancer (SCLC).

The leading Extensive-Stage Small Cell Lung Cancer Companies such as Shanghai Henlius Biotech, MacroGenics, Inc., RayzeBio, ...

Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the ... for the treatment of patients with Small Cell Lung Cancer (SCLC). SCLC is a deadly ...

Multidrug resistance in cancer can be overcome by combining a drug that blocks a key enzyme with another anticancer drug, ...

Patients with lung cancer have a high prevalence of atherosclerosis. These patients may benefit from calcium scoring. Researchers identified specific risk factors linked to atherosclerosis in this ...

Bayer continues to form new partnerships to expand its targets for cancer treatment, recently collaborating with MOMA and ...

225 Ac-satoreotide is a first-in-class Actinium-labelled somatostatin receptor 2 antagonist targeting extensive-stage Small Cell Lung Cancer or Merkel Cell Carcinoma Orphan Drug Designation ...